# Clinical Decision Support (CDS) System — Functional Requirements

This document defines the functional requirements (FR-1 through FR-31) for a Clinical Decision Support system with blockchain-enabled consent, model lifecycle management, and regulatory readiness.

---

## 1. Clinical Decision Support (CDS) Core

### FR-1: Clinical Use Case Support
- The system shall support one or more clearly defined clinical use cases (e.g., chest X-ray triage, sepsis early warning, oncology prioritization).
- Each use case shall have configurable clinical thresholds and alerting logic approved by clinical stakeholders.

### FR-2: Decision Augmentation (Not Automation)
- The system shall present AI-generated recommendations as decision support, not autonomous decisions.
- Final clinical authority shall always remain with the clinician.

### FR-3: Explainable Outputs
- The system shall provide human-interpretable explanations for each prediction (e.g., SHAP/LIME visualizations).
- Confidence scores and uncertainty indicators shall be displayed alongside predictions.

### FR-4: Clinician Override
- Clinicians shall be able to accept, override, or ignore AI recommendations.
- Override actions shall be logged for audit and model improvement purposes.

---

## 2. Data Ingestion & Management

### FR-5: Multi-Modal Data Ingestion
- The system shall ingest structured (EHR), semi-structured, and unstructured data (labs, vitals, notes, imaging).
- Supported standards shall include FHIR, HL7, DICOM, and OMOP-compatible schemas.

### FR-6: De-identification & Pseudonymization
- All PHI shall be de-identified or pseudonymized prior to AI processing where required.
- Re-identification shall be possible only within authorized clinical environments.

### FR-7: Federated Data Support
- The system shall support federated learning and/or secure enclave-based training where data centralization is restricted.

---

## 3. Consent & Privacy Management (Blockchain-Enabled)

### FR-8: Consent Representation
- Patient consent states shall be represented via smart contracts using pseudonymous identifiers.
- Consent states shall include grant, restrict, withdraw, and scope (e.g., care vs research).

### FR-9: Consent Enforcement
- The system shall enforce consent checks prior to data use for training, inference, or secondary analysis.
- Consent revocation shall immediately prevent future processing.

### FR-10: No PHI On-Chain
- The system shall never store PHI directly on-chain.
- Only hashes, timestamps, consent states, and pseudonymous references shall be written to the blockchain.

---

## 4. Model Development & Lifecycle

### FR-11: Reproducible Model Training
- All model training runs shall be reproducible with versioned code, datasets, configurations, and random seeds.
- Training metadata shall be logged and auditable.

### FR-12: Model Registry (EVM-backed)
- Each model version shall be registered on-chain with:
  - Model identifier
  - Hash of model artifacts
  - Dataset lineage hashes
  - Approval signatures

### FR-13: Model Validation
- The system shall support retrospective, external, and prospective validation workflows.
- Performance metrics shall be computed globally and by demographic subgroups.

### FR-14: Fairness Evaluation
- The system shall evaluate performance disparities across protected attributes.
- Identified biases shall trigger mitigation workflows.

---

## 5. Clinical Evaluation & Trials

### FR-15: Silent Mode Deployment
- The system shall support silent (non-interventional) deployment for prospective validation.

### FR-16: Pilot & Trial Support
- The system shall support limited clinical pilots with configurable alert visibility.
- Trial protocols and amendments shall be versioned and time-stamped.

### FR-17: Trial Auditability
- Key trial events (protocol approval, deployment, outcome analysis) shall be logged as immutable blockchain events.

---

## 6. Deployment & Integration

### FR-18: EHR Integration
- The system shall integrate with EHRs using SMART on FHIR.
- CDS outputs shall be embedded within clinician workflows.

### FR-19: API Access
- The system shall expose secure APIs for inference, monitoring, and administration.
- APIs shall enforce role-based access control.

### FR-20: Multi-Environment Support
- The system shall support development, validation, staging, and production environments with isolation controls.

---

## 7. Monitoring & Post-Market Surveillance

### FR-21: Performance Monitoring
- The system shall continuously monitor model performance, calibration, and drift.
- Threshold breaches shall generate alerts.

### FR-22: Drift Detection
- The system shall detect data drift, concept drift, and population shifts.
- Drift events shall be logged and reviewable.

### FR-23: Incident Management
- The system shall support logging, tracking, and resolution of safety incidents and complaints.
- Incident lifecycle states shall be immutably recorded on-chain.

---

## 8. Blockchain & Auditability (EVM)

### FR-24: Permissioned EVM Network
- The blockchain network shall be permissioned and restricted to approved consortium participants.
- Node access shall be role-based and auditable.

### FR-25: Immutable Audit Logs
- The system shall log the following events on-chain:
  - Data access (pseudonymized)
  - Consent changes
  - Model deployments and rollbacks
  - Safety incidents and CAPAs

### FR-26: Cryptographic Provenance
- All critical artifacts (datasets, models, reports) shall have cryptographic hashes anchored on-chain.
- Any tampering shall be detectable.

---

## 9. Governance & Compliance

### FR-27: Ethics Board Workflow
- The system shall support governance workflows for ethics board approvals and reviews.
- Decisions shall be logged as hashed, time-stamped records.

### FR-28: Regulatory Readiness
- The system shall generate audit-ready evidence for FDA, MHRA, EU AI Act, and HIPAA reviews.
- Documentation shall be traceable across the full AI lifecycle.

### FR-29: Change Management
- Model updates shall require approval workflows.
- Rollbacks shall be supported and auditable.

---

## 10. Reporting & Analytics

### FR-30: Clinician Feedback Analytics
- The system shall analyze clinician interactions (accept/override rates) to improve usability and safety.

### FR-31: Governance Dashboards
- Authorized users shall access dashboards for:
  - Model performance
  - Fairness metrics
  - Compliance status
  - Blockchain audit summaries
